Current considerations for the management of musculoskeletal pain in Asian countries: A special focus on cyclooxygenase-2 inhibitors and non-steroid anti-inflammation drugs

International Journal of Rheumatic Diseases

Volumn 15, Issue 4, 2012, Pages 341-347

  Pongparadee, Chaudakshetrin ^a   Penserga, Ester ^b   Lee, David Jeng Shiang ^c   Chen, Shun le ^d   Gill, Ranjit Singh ^e   Hamid, Abdulbar ^f   Kumthornthip, Witsanu ^g   Liu, Yi ^h   Meliala, Lucus ⁱ   Misbach, H Jusuf ^f   Tan, Kian Hian ^j   Yeap, Swan Sim ^k   Yeo, Sow Nam ^l   Lin, Hsiao Yi ^m  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^c MSD Taiwan   (Taiwan)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e Kuala Lumpur Sports Medicine Centre   (Malaysia)

^f UNIVERSITY OF INDONESIA   (Indonesia)

^g MAHIDOL UNIVERSITY   (Thailand)

^h SICHUAN UNIVERSITY   (China)

ⁱ GADJAH MADA UNIVERSITY   (Indonesia)

^j SINGAPORE GENERAL HOSPITAL   (Singapore)

^k Sime Darby Medical Centre   (Malaysia)

^l MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

^m NATIONAL YANG MING UNIVERSITY   (Taiwan)

more..

Author keywords

Asia; COX 2; Guidelines; Management; Musculoskeletal pain; NSAIDs; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ETORICOXIB; NONSTEROID ANTIINFLAMMATORY AGENT;

ASIAN; CARDIOVASCULAR SYMPTOM; CHRONIC PAIN; DUODENUM ULCER; GASTROINTESTINAL SYMPTOM; HUMAN; MUSCULOSKELETAL PAIN; OSTEOARTHRITIS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; STOMACH ULCER;

ALGORITHMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; ASIA; CHRONIC PAIN; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MANAGEMENT; HUMANS; MUSCULOSKELETAL PAIN; OSTEOARTHRITIS; PAIN CLINICS; PATIENT COMPLIANCE;

EID: 84865301890     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2012.01769.x     Document Type: Review

References (34)

1. Lazarus H, Neumann CJ (2001) Assessing undertreatment of pain: The patients' perspectives. J Pain Palliat Care Pharmacother 9, 5-34.
2. Latremoliere A, Woolf CJ (2009) Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 10, 895-926.
3. Gwilym SE, Keltner JR, Warnaby CE et al. (2009) Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteo arthritis patients. Arthritis Rheum 61, 1226-34.
4. Blyth FM, March LM, Brnabic AJ, Cousins MJ (2004) Chronic pain and frequent use of health care. Pain 111, 51-8.
5. Eriksen J, Sjøgren P, Ekholm O, Rasmussen NK (2004) Health care utilisation among individuals reporting long-term pain: an epidemiological study based on Danish National Health Surveys. Eur J Pain 8, 517-23.
6. Gerdle B, Bjork J, Henriksson C, Bengtsson A (2004) Prevalence of current and chronic pain and their influences upon work and healthcare-seeking: a population study. J Rheumatol 31, 1399-406.
7. Haq SA, Rasker JJ, Darmawan J, Chopra A (2008) WHO-ILAR-COPCORD in the Asia-Pacific: the past, present and future. Int J Rheum Dis 11, 4-10.
8. Ng KFJ, Tsui SL, Chan WS (2002) Prevalence of common chronic pain in Hong Kong adults. Clin J Pain 18, 275-81.
9. Man AKY, Chu MC, Chen PP, Ma M, Gin T (2007) Clinical experience with a chronic pain management programme in Hong Kong Chinese patients. Hong Kong Med J 13, 372-8.
10. Pither CE, Nicholas MK (1991) Psychological approached in chronic pain management. Br Med Bull 47, 743-61.
11. Misso ML, Pitt VJ, Jones KM, Barnes HN, Piterman L, Green SE (2008) Quality and consistency of clinical practice guidelines for diagnosis and management of osteoarthritis of the hip and knee: a descriptive overview of published guidelines. Med J Aust 189, 394-9.
12. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines (2000) Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 43, 1905-15.
13. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) Recommendations for the medical management of rheumatoid arthritis: 2002 update. Arthritis Rheum 46, 328-46.
14. Combe B, Landewe R, Lukas C et al. (2007) EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 66, 34-45.
15. DeHaan M, Guzman J, Bayley MT, Bell M (2007) Knee osteoarthritis clinical practice guidelines- How are we doing? J Rheumatol 4, 2099-105.
16. Stamboulian S, Choi JS, Ahn HS et al. (2010) ERK1/2 mitogen-activated protein kinase phosphorylates sodium channel Na(v)1.7 and alters its gating properties. J Neurosci 30, 1637-47.
17. Woolf CJ, American College of Physicians; American Physiological Society (2004) Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 140, 441-51.
18. Smith WL, DeWitt DL, Garavito RM (2000) Cyclooxygenases: structural, cellular, and molecular biology. Ann Rev Biochem 69, 145-82.
19. Pertusi RM (2004) Selective cyclooxygenase inhibition in pain management. J Am Osteopath Assoc 104(11 Suppl. 8), S19-24.
20. Kwong K, Lee LY (2002) PGE(2) sensitizes cultured pulmonary vagal sensory neurons to chemical and electrical stimuli. J Appl Physiol 93, 1419-28.
21. Mandadi S, Roufogalis BD (2008) ThermoTRP channels in nociceptors: taking a lead from capsaicin receptor TRPV1. Curr Neuropharmacol 6, 21-38.
22. Ma W, Quirion R (2008) Does COX2-dependent PGE2 play a role in neuropathic pain? Neurosci Lett 437, 165-9.
23. Arendt-Nielsen L, Nie H, Laursen MB, Lausen BS, Madeleine P, Simonsen OH et al. (2010) Sensitization in patients with painful knee osteoarthritis. Pain 149, 573-81.
24. Lim AYN, Doherty M (2011) What of guidelines for osteoarthritis. Int J Rheum Dis 14, 136-44.
25. Abramson SB, Weaver AL (2005) Current state of therapy for pain and inflammation. Arthritis Res Ther 7(Suppl. 4), S1-6.
26. Huang JQ, Sridhar S, Hunt RH (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in pepticulcer disease: a meta-analysis. Lancet 359, 14-22.
27. American College of Rheumatology (ACR) Subcommittee on Osteoarthritis Guidelines (2000) Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 43, 1905-15.
28. Ramey DR, Watson DJ, Yu C, Bolognese JA, Curtis SP, Reicin AS (2005) The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis. Curr Med Res Opin 21, 715-22.
29. Warner TD, Mitchell JA (2008) COX-2 Selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs. Lancet 371, 270-3.
30. Trelle S, Reichenbach S, Wandel S et al. (2011) Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 342, c7086.
31. Cannon CP, Curtis SP, FitzGerald GA, et al. (2006) Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomized comparison. Lancet 368, 1771-81.
32. The Bandolier team. Oxford league table of analgesics in acute pain. Available at URL: http://www.medicine.ox.ac.uk/bandolier/booth/painpag/Acutrev/Analgesics/Leagtab.html
33. Clarke R, Derry S, Moore RA, McQuay HJ (2009) Single dose oral etoricoxib for acute postoperative pain in adults. Cochrane Database Syst Rev, Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004309.
34. Wanders A, Heijde D, Landewé R et al. (2005) Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 52, 1756-65.